{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:55:36Z","timestamp":1780718136407,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.semarthrit.2017.12.012","type":"journal-article","created":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T17:07:32Z","timestamp":1515258452000},"page":"22-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"title":["Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients"],"prefix":"10.1016","volume":"48","author":[{"given":"Carlos","family":"Fern\u00e1ndez-D\u00edaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Loricera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santos","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"L\u00f3pez-Mej\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Ojeda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Oliv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Rodr\u00edguez-Muguruza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia E.","family":"Carreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinidad","family":"P\u00e9rez-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Retuerto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelin C.","family":"Cervantes-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan J.","family":"Flores-Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Hern\u00e1ndez-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Urruticoechea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Ma\u00edz-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Arboleya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Bonilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00cd\u00f1igo","family":"Hern\u00e1ndez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e9e","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Exp\u00f3sito-Molinero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ruibal-Escribano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"\u00c1lvarez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Blanco-Madrigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Vela-Casasempere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rodr\u00edguez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Fito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Ortiz-Sanju\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Narv\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"L\u00f3pez-Corbeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Mena-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Aguilera-Cros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Romero-Yuste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Ord\u00f3\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Villa-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Carmen","family":"Gonz\u00e9lez-Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Mora-Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Palmou-Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Gonz\u00e1lez-Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2017.12.012_bib1","doi-asserted-by":"crossref","first-page":"h6819","DOI":"10.1136\/bmj.h6819","article-title":"Management of interstitial lung disease associated with connective tissue disease","volume":"352","author":"Mathai","year":"2016","journal-title":"Br Med J"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib2","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ejim.2013.07.004","article-title":"Rheumatoid arthritis (RA) associated interstitial lung disease (ILD)","volume":"24","author":"O\u2019 Dwyer","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib3","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/09031936.00019210","article-title":"Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome","volume":"37","author":"Tsuchiya","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/rheumatology\/33.2.118","article-title":"High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease","volume":"33","author":"McDonagh","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib6","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/ard.56.10.596","article-title":"Pulmonary functions tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis","volume":"56","author":"Cortet","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/thorax.56.8.622","article-title":"Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests","volume":"56","author":"Dawson","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/03009740410005845","article-title":"Death rates and causes of death in patients with rheumatoid arthritis: a population-based study","volume":"33","author":"Sihvonen","year":"2004","journal-title":"Scand J Rheumvatol"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1378\/chest.93.1.114","article-title":"Poor prognoses in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis","volume":"93","author":"Hakala","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","article-title":"Rheumatoid arthritis\u2014interstitial lung disease associated mortality","volume":"183","author":"Olson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib11","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.semarthrit.2013.09.005","article-title":"Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review","volume":"43","author":"Roubille","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases","volume":"86","author":"Ramos-Casals","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1517\/14740338.2011.560835","article-title":"Leflunomide-induced interstitial pneumonitis might be a representative of disease-modifying antirheumatic drug-induced lung injury","volume":"10","author":"Inokuma","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.38322","article-title":"Methotrexate and lung disease in rheumatoid arthritis:a meta-analysis of randomized controlled trials","volume":"66","author":"Conway","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1759720X15612250","article-title":"Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review","volume":"7","author":"Kundan","year":"2015","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2017.12.012_bib17","first-page":"41","article-title":"Management of rheumatoid arthritis patients with interstitial lung disease: safety of biological antirheumatic drugs and assessment of pulmonary fibrosis","volume":"8","author":"Mori","year":"2015","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib18","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.4049\/jimmunol.163.12.6794","article-title":"Blockade of T cell costimulation by CTLA4-Ig inhibits lung inflammation in murine hypersensivity pneumonitis","volume":"163","author":"Israel-Assayag","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/RHU.0000000000000084","article-title":"Abatacept therapy in rheumatoid arthritis with interstitial lung disease","volume":"20","author":"Mera-Varela","year":"2014","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13075-015-0835-7","article-title":"Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor \u03b1 agents, a retrospective cohort study","volume":"17","author":"Curtis","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib22","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib23","first-page":"277","volume":"15","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib24","series-title":"Manual SEPAR de procedimientos","article-title":"Vol\u00famenes pulmonares","author":"Compte","year":"2002"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib25","unstructured":"The Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of COPD 2014; pp. 1--123. http:\/\/www.goldcopd.org"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib26","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Committee on Idiopathic Pulmonary Fibrosis","volume":"15","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib27","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","article-title":"Association of fine specifity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease","volume":"73","author":"Giles","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib28","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1183\/13993003.00357-2015","article-title":"Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease","volume":"47","author":"Solomon","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib29","first-page":"280","article-title":"Rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis: shared mechanistic and phenotypic traits suggest overlapping disease mechanisms","volume":"67","author":"Paulin","year":"2015","journal-title":"Rev Invest Clin"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3109\/s10165-010-0280-z","article-title":"Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA","volume":"20","author":"Shidara","year":"2010","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib31","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics\u2014a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib32","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10067-009-1128-9","article-title":"Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA","volume":"28","author":"Gizinski","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib33","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","article-title":"Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease","volume":"127","author":"Lee","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrrheum.2013.197","article-title":"The safety of biologic therapies in RA-associated interstitial lung disease","volume":"10","author":"Jani","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semarthrit.2010.11.002","article-title":"Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases","volume":"41","author":"Perez-Alvarez","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/MCP.0b013e3283483ea5","article-title":"Biological treatments and connective tissue disease associated interstitial lung disease","volume":"17","author":"Panopoulos","year":"2011","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib37","first-page":"4","article-title":"Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis","volume":"14","author":"Nakashita","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib38","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1007\/s00296-010-1525-z","article-title":"A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab","volume":"32","author":"Kawashiri","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib39","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jbspin.2013.03.009","article-title":"Exacerbation of combined pulmonary fibrosis and emphysema syndrome during tocilizumab therapy for rheumatoid arthritis","volume":"80","author":"Wendling","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib40","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/ard.2009.120626","article-title":"BSRBR Control Centre Consortium D P M Symmons influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib41","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/rheumatology\/ker290","article-title":"Non-infectious pulmonary toxicity of rituximab: a systematic review","volume":"51","author":"Hadjinicolaou","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib42","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1164\/rccm.200607-912OC","article-title":"Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes","volume":"175","author":"Park","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib43","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/rheumatology\/keq017","article-title":"Rheumatoid arthritis and interstitial lung disease","volume":"49","author":"Brusselle","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib44","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2169\/internalmedicine.41.867","article-title":"Nonspecific interstitial pneumonia\/fibrosis completely recovered by adding cyclophosphamide to corticosteroids","volume":"41","author":"Nanki","year":"2002","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0012-3692(15)50949-5","article-title":"Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease","volume":"130","author":"Swigris","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib46","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Raghu","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib47","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/ard.2007.080002","article-title":"Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate","volume":"67","author":"Schiff","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib48","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/ard.2008.101121","article-title":"Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors","volume":"68","author":"Westhovens","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib49","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.yexmp.2011.09.010","article-title":"The effect of CTLA-4Ig, a CD28\/B7 antagonist, on the lung inflammation and T cell subset profile during murine hypersensitivity pneumonitis","volume":"91","author":"Jim\u00e9nez-Alvarez","year":"2011","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.semarthrit.2017.12.012_bib50","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.resinv.2016.03.001","article-title":"Possible effect of abatacept on the progression of interstitial lung disease in rheumatoid arthritis patients","volume":"5","author":"Nakashita","year":"2016","journal-title":"Respir Investig"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017217306364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017217306364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T12:32:09Z","timestamp":1693398729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017217306364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0049017217306364"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2017.12.012","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2017.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}